These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33657989)

  • 1. Quercetin Induces Apoptosis in Glioblastoma Cells by Suppressing Axl/IL-6/STAT3 Signaling Pathway.
    Kim HI; Lee SJ; Choi YJ; Kim MJ; Kim TY; Ko SG
    Am J Chin Med; 2021; 49(3):767-784. PubMed ID: 33657989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibiting receptor tyrosine kinase AXL with small molecule inhibitor BMS-777607 reduces glioblastoma growth, migration, and invasion in vitro and in vivo.
    Onken J; Torka R; Korsing S; Radke J; Krementeskaia I; Nieminen M; Bai X; Ullrich A; Heppner F; Vajkoczy P
    Oncotarget; 2016 Mar; 7(9):9876-89. PubMed ID: 26848524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma.
    Sadahiro H; Kang KD; Gibson JT; Minata M; Yu H; Shi J; Chhipa R; Chen Z; Lu S; Simoni Y; Furuta T; Sabit H; Zhang S; Bastola S; Yamaguchi S; Alsheikh H; Komarova S; Wang J; Kim SH; Hambardzumyan D; Lu X; Newell EW; DasGupta B; Nakada M; Lee LJ; Nabors B; Norian LA; Nakano I
    Cancer Res; 2018 Jun; 78(11):3002-3013. PubMed ID: 29531161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small molecule inhibition of Axl receptor tyrosine kinase potently suppresses multiple malignant properties of glioma cells.
    Vouri M; An Q; Birt M; Pilkington GJ; Hafizi S
    Oncotarget; 2015 Jun; 6(18):16183-97. PubMed ID: 25980499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of IL-6/STAT3 axis and targeting Axl and Tyro3 receptor tyrosine kinases by apigenin circumvent taxol resistance in ovarian cancer cells.
    Suh YA; Jo SY; Lee HY; Lee C
    Int J Oncol; 2015 Mar; 46(3):1405-11. PubMed ID: 25544427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corosolic Acid Attenuates the Invasiveness of Glioblastoma Cells by Promoting CHIP-Mediated AXL Degradation and Inhibiting GAS6/AXL/JAK Axis.
    Sun LW; Kao SH; Yang SF; Jhang SW; Lin YC; Chen CM; Hsieh YH
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuciferine inhibits the progression of glioblastoma by suppressing the SOX2-AKT/STAT3-Slug signaling pathway.
    Li Z; Chen Y; An T; Liu P; Zhu J; Yang H; Zhang W; Dong T; Jiang J; Zhang Y; Jiang M; Yang X
    J Exp Clin Cancer Res; 2019 Mar; 38(1):139. PubMed ID: 30922391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCL6 promotes glioma and serves as a therapeutic target.
    Xu L; Chen Y; Dutra-Clarke M; Mayakonda A; Hazawa M; Savinoff SE; Doan N; Said JW; Yong WH; Watkins A; Yang H; Ding LW; Jiang YY; Tyner JW; Ching J; Kovalik JP; Madan V; Chan SL; Müschen M; Breunig JJ; Lin DC; Koeffler HP
    Proc Natl Acad Sci U S A; 2017 Apr; 114(15):3981-3986. PubMed ID: 28356518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quercetin abrogates IL-6/STAT3 signaling and inhibits glioblastoma cell line growth and migration.
    Michaud-Levesque J; Bousquet-Gagnon N; Béliveau R
    Exp Cell Res; 2012 May; 318(8):925-35. PubMed ID: 22394507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis.
    Yang YP; Chang YL; Huang PI; Chiou GY; Tseng LM; Chiou SH; Chen MH; Chen MT; Shih YH; Chang CH; Hsu CC; Ma HI; Wang CT; Tsai LL; Yu CC; Chang CJ
    J Cell Physiol; 2012 Mar; 227(3):976-93. PubMed ID: 21503893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coordinated Targeting of S6K1/2 and AXL Disrupts Pyrimidine Biosynthesis in PTEN-Deficient Glioblastoma.
    Behrmann CA; Ennis KN; Sarma P; Wetzel C; Clark NA; Von Handorf KM; Vallabhapurapu S; Andreani C; Reigle J; Scaglioni PP; Meller J; Czyzyk-Krzeska MF; Kendler A; Qi X; Sarkaria JN; Medvedovic M; Sengupta S; Dasgupta B; Plas DR
    Cancer Res Commun; 2024 Aug; 4(8):2215-2227. PubMed ID: 39087397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting LRIG2 overcomes resistance to EGFR inhibitor in glioblastoma by modulating GAS6/AXL/SRC signaling.
    Dong M; Xiao Q; Hu J; Cheng F; Zhang P; Zong W; Tang Q; Li X; Mao F; He Y; Yu X; Wan F; Lei T; Guo D; Wang B
    Cancer Gene Ther; 2020 Dec; 27(12):878-897. PubMed ID: 31988476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinome-wide shRNA screen identifies the receptor tyrosine kinase AXL as a key regulator for mesenchymal glioblastoma stem-like cells.
    Cheng P; Phillips E; Kim SH; Taylor D; Hielscher T; Puccio L; Hjelmeland AB; Lichter P; Nakano I; Goidts V
    Stem Cell Reports; 2015 May; 4(5):899-913. PubMed ID: 25921812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. d,l-Sulforaphane Induces ROS-Dependent Apoptosis in Human Gliomablastoma Cells by Inactivating STAT3 Signaling Pathway.
    Miao Z; Yu F; Ren Y; Yang J
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28054986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrimidine compounds BY4003 and BY4008 inhibit glioblastoma cells growth via modulating JAK3/STAT3 signaling pathway.
    Ahmad N; Chen L; Yuan Z; Ma X; Yang X; Wang Y; Zhao Y; Jin H; Khaidamah N; Wang J; Lu J; Liu Z; Wu M; Wang Q; Qi Y; Wang C; Zhao Y; Piao Y; Huang R; Diao Y; Deng S; Shu X
    Neurotherapeutics; 2024 Sep; 21(5):e00431. PubMed ID: 39153914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axl and growth arrest-specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme.
    Hutterer M; Knyazev P; Abate A; Reschke M; Maier H; Stefanova N; Knyazeva T; Barbieri V; Reindl M; Muigg A; Kostron H; Stockhammer G; Ullrich A
    Clin Cancer Res; 2008 Jan; 14(1):130-8. PubMed ID: 18172262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the Receptor Tyrosine Kinase AXL in Response to Therapy and Its Role in Therapy Resistance in Glioblastoma.
    Scherschinski L; Prem M; Kremenetskaia I; Tinhofer I; Vajkoczy P; Karbe AG; Onken JS
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian regulator NR1D2 regulates glioblastoma cell proliferation and motility.
    Yu M; Li W; Wang Q; Wang Y; Lu F
    Oncogene; 2018 Aug; 37(35):4838-4853. PubMed ID: 29773903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RBPJ contributes to the malignancy of glioblastoma and induction of proneural-mesenchymal transition via IL-6-STAT3 pathway.
    Zhang G; Tanaka S; Jiapaer S; Sabit H; Tamai S; Kinoshita M; Nakada M
    Cancer Sci; 2020 Nov; 111(11):4166-4176. PubMed ID: 32885530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma.
    Ashizawa T; Miyata H; Iizuka A; Komiyama M; Oshita C; Kume A; Nogami M; Yagoto M; Ito I; Oishi T; Watanabe R; Mitsuya K; Matsuno K; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Nakasu Y; Yamaguchi K; Akiyama Y
    Int J Oncol; 2013 Jul; 43(1):219-27. PubMed ID: 23612755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.